<DOC>
	<DOC>NCT00185354</DOC>
	<brief_summary>The purpose of this study is to compare bleeding pattern and safety of contraceptive patch SH P00331F to a marketed comparator.</brief_summary>
	<brief_title>FC Patch Comparator Study</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<criteria>Healthy female volunteer aged 1835, smokers 1830 Contraindications for using hormonal contraceptives</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>FC patch</keyword>
	<keyword>comparator study</keyword>
</DOC>